mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BRD-K61166597 |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.2 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
B02 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.2 |
mRNA |
PF-750 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |
mRNA |
ML210 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.2 |